Biostage Analysis

BSTGDelisted Stock  USD 4.20  0.09  2.10%   
Biostage is overvalued with Real Value of 3.86 and Hype Value of 4.2. The main objective of Biostage otc analysis is to determine its intrinsic value, which is an estimate of what Biostage is worth, separate from its market price. There are two main types of Biostage's stock analysis: fundamental analysis and technical analysis.
The Biostage otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Biostage's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Biostage OTC Stock Analysis Notes

About 51.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.89. Biostage last dividend was issued on the 22nd of December 2017. The entity had 1:20 split on the 22nd of December 2017. Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts. Biostage operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 6 people.The quote for Biostage is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Biostage please contact David Green at 774 233 7300 or go to https://biostage.com.

Biostage Investment Alerts

Biostage is not yet fully synchronised with the market data
Biostage has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (7.98 M) with profit before overhead, payroll, taxes, and interest of 0.
Biostage currently holds about 4.64 M in cash with (2.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4.
Roughly 51.0% of the company shares are held by company insiders

Biostage Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Biostage previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
3rd of August 2023
Upcoming Quarterly Report
View
30th of June 2023
Next Fiscal Quarter End
View

Biostage Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 73.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biostage's market, we take the total number of its shares issued and multiply it by Biostage's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Biostage Outstanding Bonds

Biostage issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biostage uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biostage bonds can be classified according to their maturity, which is the date when Biostage has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Biostage Predictive Daily Indicators

Biostage intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Biostage otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

About Biostage OTC Stock Analysis

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Biostage prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biostage shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Biostage. By using and applying Biostage OTC Stock analysis, traders can create a robust methodology for identifying Biostage entry and exit points for their positions.
Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts. Biostage operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 6 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Biostage to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Top Crypto Exchanges Now

   

Top Crypto Exchanges

Search and analyze digital assets across top global cryptocurrency exchanges
All  Next Launch Module
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Consideration for investing in Biostage OTC Stock

If you are still planning to invest in Biostage check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biostage's history and understand the potential risks before investing.
CEOs Directory
Screen CEOs from public companies around the world
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites